Assignee
NEUROTECH SA
FR·21 granted patents·1 pending application·1,622 citations·filing 1995–2012
Top patents by PatentIndex Score
22 records- 0197US6231879B1Biocompatible devices with foam scaffoldsNEUROTECH SA·Filed 1997·Granted May 15, 2001·397 cites·8 claims
- 0296US6436427B1Device and method for treating ophthalmic diseasesNEUROTECH SA·Filed 2001·Granted Aug 20, 2002·137 cites·7 claims
- 0395US6299895B1Device and method for treating ophthalmic diseasesNEUROTECH SA·Filed 1997·Granted Oct 9, 2001·231 cites·50 claims
- 0495US6156572ABioartificial extracellular matrix containing hydrogel matrix derivatized with cell adhesive peptide fragmentNEUROTECH SA·Filed 1998·Granted Dec 5, 2000·138 cites·8 claims
- 0594US6361771B1ARPE-19 as a platform cell line for encapsulated cell-based deliveryNEUROTECH SA·Filed 2000·Granted Mar 26, 2002·102 cites·14 claims
- 0694US6322804B1Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic productsNEUROTECH SA·Filed 2000·Granted Nov 27, 2001·39 cites·5 claims
- 0791US7115257B1ARPE-19 as a platform cell line for encapsulated cell-based deliveryNEUROTECH SA·Filed 2000·Granted Oct 3, 2006·50 cites·3 claims
- 0889US6225448B11gG /transferrin receptor fusion proteinNEUROTECH SA·Filed 2000·Granted May 1, 2001·29 cites·1 claims
- 0989US6180007B1Membrane formed by an acrylonitrile-based polymerNEUROTECH SA·Filed 1998·Granted Jan 30, 2001·53 cites·9 claims
- 1086US6303136B1Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membraneNEUROTECH SA·Filed 1999·Granted Oct 16, 2001·152 cites·12 claims
- 1183US6495364B2Mx-1 conditionally immortalized cellsNEUROTECH SA·Filed 2001·Granted Dec 17, 2002·24 cites·2 claims
- 1283US6392118B1Mx-1 conditionally immortalized cellsNEUROTECH SA·Filed 1995·Granted May 21, 2002·39 cites·12 claims
- 1379US6627422B1Device containing cell-supporting yarn matrix encapsulated in a semi-permeable membraneNEUROTECH SA·Filed 1999·Granted Sep 30, 2003·94 cites·8 claims
- 1474US6264941B1Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsulesNEUROTECH SA·Filed 1999·Granted Jul 24, 2001·21 cites·2 claims
- 1571US6649184B2Device and method for treating ophthalmic diseasesNEUROTECH SA·Filed 2002·Granted Nov 18, 2003·39 cites·3 claims
- 1671US6197294B1Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 1998·Granted Mar 6, 2001·21 cites·6 claims
- 1769US6878544B2Retinal cell lines with extended life-span and their applicationsNEUROTECH SA·Filed 2000·Granted Apr 12, 2005·4 cites·1 claims
- 1867US6506891B2Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 2001·Granted Jan 14, 2003·2 cites·1 claims
- 1966US6090624AImmortalized retinal cell lines and their applicationsNEUROTECH SA·Filed 1998·Granted Jul 18, 2000·30 cites·10 claims
- 2065US6183735B1Immortalized retinal pigmentary epithelial cell lines and their applicationsNEUROTECH SA·Filed 1997·Granted Feb 6, 2001·20 cites·13 claims
- 2154US7189837B2Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 2003·Granted Mar 13, 2007·0 cites·5 claims
- 2233US2015238758A1Device for electrochemically releasing a composition in a controlled mannerNEUROTECH SA·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →